Results 31 to 40 of about 7,843,232 (348)

Translating the combination of gene therapy and tissue engineering for treating recessive dystrophic epidermolysis bullosa [PDF]

open access: yesEuropean Cells & Materials, 2018
The combination of gene therapy and tissue engineering is one of the most promising strategies for the treatment of recessive dystrophic epidermolysis bullosa (RDEB).
A Dakiw Piaceski   +8 more
doaj   +1 more source

Highly Efficient and Selective CAR-Gene Transfer Using CD4- and CD8-Targeted Lentiviral Vectors

open access: yesMolecular Therapy: Methods & Clinical Development, 2019
Chimeric antigen receptor (CAR)-modified T cells have revealed promising results in the treatment of cancer, but they still need to overcome various hurdles, including a complicated manufacturing process.
Arezoo Jamali   +5 more
doaj   +1 more source

HoxA9 binds and represses the Cebpa +8 kb enhancer [PDF]

open access: yes, 2019
C/EBPα plays a key role in specifying myeloid lineage development. HoxA9 is expressed in myeloid progenitors, with its level diminishing during myeloid maturation, and HOXA9 is over-expressed in a majority of acute myeloid leukemia cases, including those
Aplan, Peter D.   +7 more
core   +2 more sources

Muscle fiber type-predominant promoter activity in lentiviral-mediated transgenic mouse. [PDF]

open access: yesPLoS ONE, 2011
Variations in gene promoter/enhancer activity in different muscle fiber types after gene transduction was noticed previously, but poorly analyzed. The murine stem cell virus (MSCV) promoter drives strong, stable gene expression in hematopoietic stem ...
Tomohiro Suga   +10 more
doaj   +1 more source

A lentiviral vector B cell gene therapy platform for the delivery of the anti-HIV-1 eCD4-Ig-knob-in-hole-reversed immunoadhesin

open access: yesMolecular Therapy: Methods & Clinical Development, 2023
Barriers to effective gene therapy for many diseases include the number of modified target cells required to achieve therapeutic outcomes and host immune responses to expressed therapeutic proteins.
Eirini Vamva   +14 more
doaj   +1 more source

C/EBPβ-1 promotes transformation and chemoresistance in Ewing sarcoma cells. [PDF]

open access: yes, 2017
CEBPB copy number gain in Ewing sarcoma was previously shown to be associated with worse clinical outcome compared to tumors with normal CEBPB copy number, although the mechanism was not characterized.
Abegglen, Lisa M   +12 more
core   +1 more source

Identification and Functional Characterization of a Smad Binding Element (SBE) in the JunB Promoter That Acts as a Transforming Growth Factor-β, Activin, and Bone Morphogenetic Protein-inducible Enhancer*

open access: yesJournal of Biological Chemistry, 1998
Smad proteins have been identified as mediators of intracellular signal transduction by members of the transforming growth factor-β (TGF-β) superfamily, which affect cell proliferation, differentiation, as well as pattern formation during early ...
L. Jonk   +4 more
semanticscholar   +1 more source

miR-19a: An Effective Regulator of SOCS3 and Enhancer of JAK-STAT Signalling

open access: yesPLoS ONE, 2013
Suppressors of cytokine signalling (SOCS) proteins are classic inhibitors of the Janus kinase-signal transducer and activator of transcription (JAK-STAT) pathway.
Aideen S. Collins   +4 more
semanticscholar   +1 more source

Extinction of tyrosine aminotransferase gene activity in somatic cell hybrids involves modification and loss of several essential transcription factors [PDF]

open access: yes, 1993
Extinction is defined as the loss of cell type-specific gene expression that occurs in somatic cell hybrids derived by fusion of cells with dissimilar phenotypes.
Boshart, Michael   +2 more
core   +1 more source

MYC Deregulation in Primary Human Cancers

open access: yesGenes, 2017
MYC regulates a complex biological program by transcriptionally activating and repressing its numerous target genes. As such, MYC is a master regulator of many processes, including cell cycle entry, ribosome biogenesis, and metabolism.
M. Kalkat   +8 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy